Liu Fang

《 》、《 》、《 》; “ ” “ ”; “ ”. 、.;;;《 》;《 》;《 》.. 4 ( 1 、 1 、 2 ).2004,2016.2018. SCI 、 60, 30. [1]Yi ZM, Zhai SD, Huang S, Wang TS, Liu F*. Off-label prescriptions for adult neurological patients: a pilot survey in China. Int J Clin Pharm.2012 Int J Clin Pharm. 2012 Feb;34(1):81-7. [2], *.246..2011,13(6):354-358 [3], *,...2013,24(4):349-351 [4],,,,. 116 [J].,2014,21:1961-1965. [5],, *,,,,. IVIG: [J].,2015,08:734-738. [6],, *,,. [J]. Journal of Chinese Pharmaceutical Sciences,2016,01:66-72. [7],,,, *. Influence of voriconazole on pharmacokinetics and safety of combined drugs: a syetematic review. Journal of Chinese Pharmaceutical Sciences.2016,11:785-798 [8]Liu F, Wang HM, Wang T, Zhang YM, Zhu X. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials. BMC Infect Dis. 2016 Sep 15;16:488. doi: 10.1186/s12879-016-1823-5. PubMed PMID: 27633969; PubMed Central PMCID: PMC5025565. [9]Li TY, Liu W, Chen K, Liang SY, Liu F*.The influence of combination use ofCYP450 inducers on the pharmacokinetics of voriconazole: a systematic review. J Clin Pharm Ther. 2017 Apr;42(2):135-146. [10],,,. [J]., 2018,53(17):1523-1528. [11],,. [J]., 2018,20(5):321-323. [12] Zhang X, Zhu Z, Jiao W, Liu W, Liu F*, Zhu X. Ulinastatin treatment for acute respiratory distress syndrome in China: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2019 Nov 4;19(1):196. doi: 10.1186/s12890-019-0968-6. PMID: 31684936; PMCID: PMC6829844 《 》 (,,,517,2016) 《 》 (,,,406,2019)